SLC16A1 and breast cancer: Meanwhile, miR-552-5p expression in the cancerous tissues was significantly upregulated (Figure 4E, p < 0.01) and negatively correlated to SLC16A1-AS1 expression in the 80 BC patients included by Spearman correlation analysis (Figure 4F, p < 0.001), indicating that miR-552-5p acted as an oncogenic miRNA in BC.